[1] YELLON D M,HAUSENLOY D J.Myocardial reperfusion injury[J].N Engl J Med,2007,357(11):1121-1135.
[2] 吕磊,孟庆欣,徐军,等.川芎嗪对大鼠心肌再灌注损伤保护机制的实验研究[J].东南大学学报:医学版,2012,31(4):410-414.
[3] IBARRA-LARA L,HONG E,SORIA-CASTRO E,et al.Clofibrate PPARα activation reduces oxidative stress and improves ultrastructure and ventricular hemodynamics in no-flow myocardial ischemia[J].J Cardiovasc Pharmacol,2012,60(4):323-334.
[4] RAVINGEROVÁ T,CARNICKÁ S,NEMČEKOVÁ M,et al.PPAR-alpha activation as a preconditioning like intervention in rats in vivo confers myocardial protection against acute ischaemia-reperfusion injury:involvement of PI3K-Akt[J].Can J Physiol Pharmacol,2012,90(8):1135-1144.
[5] SUGGA G S,KHAN M U,KHANAM R.Protective role of fibrates in cardiac ischemia/reperfusion[J].J Adv PharmTechnol Res,2012,3(3):188-192.
[6] NEMČEKOVÁ M,ČARNICKÁ S,FERKO M,et al.Treatment of rats with hypolipidemic compound pirinixic acid protects their hearts against ischemic injury:are mitochondrial K(ATP) channels and reactive oxygen species involved?[J].Physiol Res,2013,62(5):577-584.
[7] GUELLICH A,DAMY T,LECARPENTIER Y,et al.Role of oxidative stress in cardiac dysfunction of PPARalpha-/-mice[J].Am J Physiol Heart Circ Physiol,2007,293(1):H93-H102.
[8] YOON M.PPARα in obesity:sex difference and estrogen involvement[J].PPAR Res,2010,2010:584296.
[9] KONG L,REN W,LI W,et al.Activation of peroxisome proliferator activated receptor alpha ameliorates ethanol induced steatohepatitis in mice[J].Lipids Health Dis,2011,10(3):321-328.
[10] NAN Y M,WANG R Q,FU N.Peroxisome proliferator-activated receptor α,a potential therapeutic target for alcoholic liver disease[J].World J Gastroenterol,2014,20(25):8055-8060.
[11] WANG R Q,NAN Y M,WU W J,et al.Induction of heme oxygenase-1 protects against nutritional fibrosing steatohepatitis in mice[J].Lipids Health Dis,2011,10(12):31.
[12] CHEN K,LI Y H,XU S Q,et al.Protective effects of peroxisome proliferator-activated receptor-α agonist,Wy14643,on hypoxia/reoxygenation injury in primary rat hepatocytes[J].PPAR Res,2012,2012:547980.
[13] PATTERSON A D,SHAH Y M,MATSUBARA T,et al.PPARα-dependent induction of uncoupling protein 2 protects against acetaminophen-induced liver toxicity[J].Hepatology (Baltimore,Md),2012,56(1):281-290.
[14] CHENG C F,CHEN H H,LIN H.Role of PPARα and its agonist in renal diseases[J].PPAR Res,2010,2010:345098.
[15] HOU X,SHEN Y H,LI C,et al.PPARα agonist fenofibrate protects the kidney from hypertensive injury in spontaneously hypertensive rats via inhibition of oxidative stress and MAPK activity[J]. Biochem Biophy Res Commun,2010,394(3):653-659.
[16] GELOSA P,BANFI C,GIANELLA A,et al,et al.Peroxisome proliferator-activated receptor alpha agonism prevents renal damage and the oxidative stress and inflammatory processes affecting the brains of stroke-prone rats[J].J Pharmacol Exp Ther,2010,335(2):324-331.
[17] IBRAHIM M A,EI-SHEIKH A A,KHALAF H M,et al.Protective effect of peroxisome proliferator activator receptor (PPAR)-α and-γ ligands against methotrexate-induced nephrotoxicity[J].Immunopharmacol Immunotoxicol,2014,36(2):130-137.
[18] CHUNG H W,LIM J H,KIM M Y,et al.High-fat diet-induced renal cell apoptosis and oxidative stress in spontaneously hypertensive rat are ameliorated by fenofibrate through the PPARα-FoxO3a-PGC-1α pathway[J].Nephrol Dial Transplant,2012,27(6):2213-2225.
[19] 刘莉.神经节苷脂GM1对6-OHDA诱导的PC12细胞氧化应激的保护作用[J].现代医学,2014,42(4):359-362.
[20] BARBIERO J K,SANTIAGO R,TONIN F S,et al.PPAR-α agonist fenofibrate protects against the damaging effects of MPTP in a rat model of Parkinson's disease[J]. Prog Neuropsychopharmacol Biol Psychiatry,2014,53(4):35-44.
[21] BHATEJA D K,DHULL D K,GILL A,et al.Peroxisome proliferator-activated receptor-α activation attenuates 3-nitropropionic acid induced behavioral and biochemical alterations in rats:Possible neuroprotective mechanisms[J].Eur J Pharmacol,2012,674(1):33-43.
[22] WANG G,LIU X,GUO Q,et al.Chronic treatment with fibrates elevates superoxide dismutase in adult mouse brain microvessels[J].Brain Res,2010,1359(4):247-255.
[23] MOHAGHEGHI F,KHALAJ L,AHMADIANI A,et al.Gemfibrozil pretreatment affecting antioxidant defense system and inflammatory,but not Nrf-2 signaling pathways resulted in female neuroprotection and male neurotoxicity in the rat models of global cerebral ischemia-reperfusion[J].Neurotox Res,2013,23(3):225-237.
[24] BEATTY S,KOH H,PHIL M,et al.The role of oxidative stress in the pathogenesis of age-related macular degeneration[J].Surv Ophthalmol,2000,45(2):115-134.
[25] DENTCHEV T,HAHN P,DUNAIEF J L.Strong labeling for iron and the iron-handling proteins ferritin and ferroportin in the photoreceptor layer in age-related macular degeneration[J].Arch Ophthalmol,2005,123(12):1745-1746.
[26] SUR A,KESARAJU S,PRENTICE H,et al.Pharmacological protection of retinal pigmented epithelial cells by sulindac involves PPARα[J].Proc Natl Acad Sci USA,2014,111(47):16754-16759.
[27] MORAN E,DING L,WANG Z,et al.Protective and antioxidant effects of PPARα in the ischemic retina[J].Invest Ophthalmol Vis Sci,2014,55(7):4568-4576.
[28] KEECH A C,MITCHELL P,SUMMANEN P A,et al.Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study):a randomised controlled trial[J].Lancet,2007,370(9600):1687-1697.
[29] GROUP A S,GROUP A E S,CHEW E Y,et al.Effects of medical therapies on retinopathy progression in type 2 diabetes[J].N Engl J Med,2010,363(3):233-244.
[30] KIM T,YANG Q.Peroxisome-proliferator-activated receptorsregulate redox signaling in the cardiovascular system[J].World J Cardiol,2013,5(6):164-174.
[31] KHOO N K,HEBBAR S,ZHAO W,et al.Differential activation of catalase expression and activity by PPAR agonists:implications for astrocyte protection in anti-glioma therapy[J].Redox Biol,2013,1:70-79.
[32] LIU X,JANG S S,AN Z,et al.Fenofibrate decreases radiation sensitivity via peroxisome proliferator-activated receptor α-mediated superoxide dismutase induction in HeLa cells[J].Radiat Oncol J,2012,30(2):88-95.
[33] LI J L,WANG Q Y,LUAN H Y,et al.Effects of L-carnitine against oxidative stress in human hepatocytes:involvement of peroxisome proliferator-activated receptor alpha[J].J Biomed Sci,2012,19:32.
[34] BILLIET L,FURMAN C,CUAZ-PÉROLIN C,et al.Thioredoxin-1 and its natural inhibitor,vitamin D3 up-regulated protein 1,are differentially regulated by PPARalpha in human macrophages[J].J Mol Biol,2008,384(3):564-576.
[35] GIRNUN G D,DOMANN F E,MOORE S A,et al.Identification of a functional peroxisome proliferator-activated receptor response element in the rat catalase promoter[J].Mol Endocrinol,2002,16(12):2793-2801.
[36] 廖新学,郭瑞鲜,马虹,等.血管紧张素-(1-7)对心肌缺血再灌注引起氧化应激及心功能变化的影响[J].南方医科大学学报,2008,28(8):1345-1348. |
